Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3760779017 | Carmellose- and hydroxyapatite-containing product in parenteral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3760780019 | Product containing carmellose and hydroxyapatite in parenteral dose form (medicinal product form) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3760781015 | Carboxymethylcellulose- and hydroxyapatite-containing product in parenteral dose form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 4042418019 | Product containing carmellose and durapatite in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 4042419010 | Carboxymethylcellulose- and durapatite-containing product in parenteral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing carmellose and durapatite in parenteral dose form (medicinal product form) | Is a | Product containing carmellose and durapatite (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing carmellose and durapatite in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing carmellose and durapatite in parenteral dose form (medicinal product form) | Is a | Product containing durapatite in parenteral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing carmellose and durapatite in parenteral dose form (medicinal product form) | Has active ingredient | Carmellose | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing carmellose and durapatite in parenteral dose form (medicinal product form) | Has active ingredient | Hydroxyapatite | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing carmellose and durapatite in parenteral dose form (medicinal product form) | Has active ingredient | Hydroxyapatite | true | Inferred relationship | Existential restriction modifier | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only carmellose and durapatite in parenteral dose form (medicinal product form) | Is a | True | Product containing carmellose and durapatite in parenteral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR